Record

RefNoEC/2009/38
LevelItem
TitleStevens, Malcolm: certificate of election to the Royal Society
Date14 May 2009
DescriptionMalcolm Stevens is distinguished for his elegant design and invention of small nitrogen-based heterocycles for treatment of cancer. He is the inventor of 'temozolomide' which is active against brain tumours and licensed by Cancer Research Technologies to Schering Plough Corporation, with sales of $300 million/annum, rising. Three other compounds discovered in his laboratories, ie N-methylformamide, bropirimine and MZPES, have progressed to clinical trials, and bropirimine is now on the market in Japan as RemisarTM. The antitumoral benzothiazole 'phortress' synthesised in Stevens' laboratory has recently been selected for clinical trials in 2003 by Cancer Research UK and the National Cancer Institute.
Extent6p
FormatPrinted
AccessStatusClosed
Add to My Items

    Collection highlights

    Browse the records of some of our collections, which cover all branches of science and date from the 12th century onwards. These include the published works of Fellows of the Royal Society, personal papers of eminent scientists, letters and manuscripts sent to the Society or presented at meetings, and administrative records documenting the Society's activities since our foundation in 1660.

    The Royal Society

    The Royal Society is a Fellowship of many of
    the world's most eminent scientists and is the
    oldest scientific academy in continuous existence.
    Registered charity number 207043

    Website design ©CalmView



    CONTACT US

    + 44 207 451 2500
    (Lines open Mon-Fri, 9:00-17:00. Excludes bank holidays)

    6-9 Carlton House Terrace, London SW1Y 5AG

    Email Us →

    SUBSCRIBE

    Subscribe to our newsletters to be updated with the
    latest news on innovation, events, articles and reports.

    Subscribe →

    © CalmView